Classes
DEA Class; Rx
Common Brand Names; Carmol HC, U-Cort
- Corticosteroids, Topical
Description
Hydrocortisone: anti-inflammatory, antipruritic and vasoconstrictive actions; mechanism of anti-inflammatory activity of topical corticosteroids unclear
Indications
Indicated for relief of inflammation and pruritic associated with corticosteroid-responsive dermatoses
Extent determined by many factors including vehicle, integrity of epidermal barrier, use of occlusive dressings
Contraindications
Hypersensitivity to any components of preparation
Hepatic insufficiency
Adverse Effects
- Burning
- Itching
- Irritation
- Dryness
- Folliculitis
- Hypertrichosis
- Acneiform eruptions
- Hypopigmentation
- Perioral dermatitis
- Allergic contact dermatitis
- Maceration of the skin
- Secondary infection
- Skin atrophy
- Striae
- Miliaria
Warnings
Prolonged use may result in fungal or bacterial infection
Contains sodium metabisulfite, which may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people
Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing’s syndrome, hyperglycemia and glucosuria
Conditions which augment systemic absorption include the application of the more potent steroids, use over large surface areas, prolonged use and the addition of occlusive dressings Evaluate susceptible patients periodically for evidence of HPA axis suppression by using the urinary free cortisol and ACTH stimulation tests; If HPA axis suppression is noted, withdraw the drug, reduce frequency of application, or substitute less potent steroid
Pregnancy and Lactation
Pregnancy Category: C
Lactation: Systemic hydrocortisone is excreted in breast milk, use caution
Maximum Dosage
Apply to affected area q6-12hr; discontinue therapy when control achieved
If no improvement within 2 weeks, reassess diagnosis
Pediatric
Apply to affected area q6-12hr; discontinue therapy when control achieved
If no improvement within 2 weeks, reassess diagnosis
How supplied
Urea/hydrocortisone topical
topical cream
- 10%/1%